These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6986204)

  • 21. Immune interferon activates cells more slowly than does virus-induced interferon.
    Dianzani F; Salter L; Fleischmann WR; Zucca M
    Proc Soc Exp Biol Med; 1978 Oct; 159(1):94-7. PubMed ID: 714938
    [No Abstract]   [Full Text] [Related]  

  • 22. Potentiation of interferon action.
    Schwarz LA; Fleischmann WR
    Tex Rep Biol Med; 1981-1982; 41():298-306. PubMed ID: 6184817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristics of immune interferon produced by human lymphocyte cultures compared to other human interferons.
    Valle MJ; Jordan GW; Haahr S; Merigan TC
    J Immunol; 1975 Jul; 115(1):230-3. PubMed ID: 239056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Purification and properties of native and modified interferons.
    Pickering LA; Braude IA; Lin LS; Stewart WE
    Ann N Y Acad Sci; 1980; 350():354-63. PubMed ID: 6165287
    [No Abstract]   [Full Text] [Related]  

  • 25. Enhancement of T cell cytotoxic responses by purified human fibroblast interferon.
    Zarling JM; Sosman J; Eskra L; Borden EC; Horoszewicz JS; Carter WA
    J Immunol; 1978 Nov; 121(5):2002-4. PubMed ID: 309487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mediators of cellular immune reactions.
    Hanson JM; Rumjanek VM; Morley J
    Pharmacol Ther; 1982; 17(2):165-98. PubMed ID: 6184737
    [No Abstract]   [Full Text] [Related]  

  • 27. [Concentration of heterogeneous leukocyte interferon].
    Solov'ev VD; Parfenov VV; Zubanova NA; Pokidysheva LN; Tkach TA
    Vopr Virusol; 1981; (6):720-4. PubMed ID: 6175114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potentiation of the direct anticellular activity of mouse interferons: mutual synergism and interferon concentration dependence.
    Fleischmann WR
    Cancer Res; 1982 Mar; 42(3):869-75. PubMed ID: 6174218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antigenic properties of crossprotecting factors in human leukocyte and mouse L cell interferons.
    Paucker K; Dalton BJ
    Ann N Y Acad Sci; 1980; 350():332-8. PubMed ID: 6165285
    [No Abstract]   [Full Text] [Related]  

  • 30. Protection of newborn mice from a lethal herpes simplex virus infection by human interferon, antibody, and leukocytes.
    Kohl S; Loo LS; Greenberg SB
    J Immunol; 1982 Mar; 128(3):1107-11. PubMed ID: 6173420
    [No Abstract]   [Full Text] [Related]  

  • 31. Priming of interferon action.
    Fleischmann WR
    Tex Rep Biol Med; 1977; 35():316-25. PubMed ID: 616670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tolerability of pure fibroblast interferon in man.
    Billiau A; Heine JW; Van Damme J; Heremans H; De Somer P
    Ann N Y Acad Sci; 1980; 350():374-5. PubMed ID: 6165288
    [No Abstract]   [Full Text] [Related]  

  • 33. Immune reactions and long-term therapy with human leukocyte interferon.
    Ingimarsson S; Cantell K; Carlström G; Dalton B; Paucker K; Strander H
    Acta Med Scand; 1981; 209(1-2):17-19. PubMed ID: 6163328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Guinea pig lymphotoxin. II. Study of its mechanism of action. Its differentiation from migration inhibitory factor and interferon.
    Goguel AF; Nauciel C
    Ann Immunol (Paris); 1974; 125 C(5):789-802. PubMed ID: 4617553
    [No Abstract]   [Full Text] [Related]  

  • 35. Production, purification and clinical application of human fibroblast interferon.
    Carter WA; Horoszewicz JS
    Pharmacol Ther; 1980; 8(2):359-77. PubMed ID: 6155675
    [No Abstract]   [Full Text] [Related]  

  • 36. Growth-inhibitory and antiviral activity of purified leukocyte interferon.
    Evinger M; Rubinstein M; Pestka S
    Ann N Y Acad Sci; 1980; 350():399-404. PubMed ID: 6165289
    [No Abstract]   [Full Text] [Related]  

  • 37. Intercellular communication: role of soluble factors in cellular immune responses.
    Klesius PH
    J Am Vet Med Assoc; 1982 Nov; 181(10):1015-21. PubMed ID: 6816771
    [No Abstract]   [Full Text] [Related]  

  • 38. Induction and production of human interferon with a continuous line of modifies fibroblasts.
    Tan YH
    Methods Enzymol; 1981; 78(Pt A):120-5. PubMed ID: 6173575
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunoregulation by lymphokines: immune interferon and lymphotoxin induction of lymphokine activity in human peripheral blood leukocyte cultures.
    Robbins CH
    Adv Exp Med Biol; 1983; 166():37-44. PubMed ID: 6196957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Human interferons -- features and chances (author's transl)].
    Pohl A; Moser K; Micksche M
    Wien Klin Wochenschr; 1981 Jul; 93(14):439-57. PubMed ID: 6168122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.